Zevra Therapeutics (ZVRA) Tax Rate (2014 - 2026)

Zevra Therapeutics has reported Tax Rate for 13 years, with the latest figure at 15.43% in Q1 2026.

• For the quarter ending Q1 2026, Tax Rate rose 7709.0% year-over-year to 15.43%; the trailing twelve-month figure through Mar 2026 stood at 6.88% (up 2894.0% YoY), and the FY2025 full-year result was 3.98%, up 2103.0% from the prior year.
• Tax Rate for Q1 2026 stood at 15.43%, up from 3.96% in the prior quarter.
• The five-year high for Tax Rate was 44.32% in Q3 2025, with the low at 75.47% in Q4 2024.
• Historically, Tax Rate has averaged 4.72% across 5 years, with a median of 0.68% in 2022.
• The largest YoY upside for Tax Rate was 7942 bps in 2025 against a maximum downside of 6208 bps in 2025.
• Zevra Therapeutics' Tax Rate stood at 2.17% in 2022, then tumbled by 180 bps to 1.74% in 2023, then tumbled by 4245 bps to 75.47% in 2024, then surged by 105 bps to 3.96% in 2025, then soared by 290 bps to 15.43% in 2026.
• The last three Tax Rate figures came in at 15.43% (Q1 2026), 3.96% (Q4 2025), and 44.32% (Q3 2025), per Business Quant data.